Skip to content
Companies

Voxcell BioInnovation

3D bioprinted tumor models for drug testing

Raised to date

Not disclosed

No Form D filings on record

Investors
10

About

VoxCell BioInnovation Inc. is a pioneering biotechnology company specializing in innovative solutions to enhance the drug development process, particularly within the oncology sector. By focusing on reducing the high failure rate in drug development, VoxCell aims to streamline preclinical testing and ultimately decrease both time and costs involved.

VoxCell stands out with its state-of-the-art 3D bioprinting technologies and unique vascularized cancer tissue models, which provide a more accurate representation of human tumors.

Product

Vascularized Cancer Tissue Models

Bioprinted Models

VoxCell's vascularized cancer tissue models are advanced 3D bioprinted constructs that closely mimic the tumor microenvironment. These models serve as effective screening platforms for drug candidates in preclinical testing, providing researchers and pharmaceutical companies with valuable data regarding the efficacy of potential therapies.

  • 3D bioprinted human-like structures
  • Replicates tumor microenvironment
  • Enhances accuracy in drug testing

Built for

Pharmaceutical companies and oncology researchers